ATRHIGH SIGNALFINANCIAL10-K

ATR executed a massive $365M share buyback program while dramatically increasing gross profit by 287% and significantly expanding its balance sheet through debt financing.

The company reduced outstanding shares from 66.5M to 64.4M through aggressive capital allocation, returning substantial cash to shareholders while simultaneously growing operations. The debt increase of 66% to $1.1B suggests either acquisition activity or significant capital investment to drive the dramatic gross profit expansion, positioning the company for accelerated growth.

Comparing 2026-02-06 vs 2025-02-07View on EDGAR →
FINANCIAL ANALYSIS

ATR's financial profile transformed significantly with gross profit surging 287% to $906M while the company executed a massive $365M share buyback (up 432% from prior year), funded partly through increased debt levels that rose 66% to $1.1B. Despite operating cash flow declining 11% to $570M, the company strengthened its cash position by 80% to $402M and expanded total assets 19% to $5.3B, indicating substantial business expansion likely through acquisitions or major capital investments. The combination of aggressive share repurchases, debt-financed growth, and dramatic profit expansion signals a company in active transformation mode.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+431.8%
$68.6M→$365.0M

Share repurchases increased 431.8% — management returning capital, signals confidence in intrinsic value.

Gross Profit
P&L
+287.2%
$234.0M→$906.0M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Cash & Equivalents
Balance Sheet
+79.8%
$223.8M→$402.4M

Cash position surged 79.8% — strong cash generation or capital raise providing significant financial cushion.

Total Debt
Balance Sheet
+65.6%
$688.1M→$1.1B

Debt increased 65.6% — substantial leverage increase; assess whether deployed for growth or covering losses.

Current Assets
Balance Sheet
+28.1%
$1.5B→$1.9B

Current assets grew 28.1% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+18.5%
$4.4B→$5.3B

Asset base grew 18.5% — expansion through organic growth, acquisitions, or capital deployment.

Inventory
Balance Sheet
+16.5%
$461.8M→$537.8M

Inventory built 16.5% — monitor whether demand supports this build or if write-downs may follow.

Operating Cash Flow
Cash Flow
-11.4%
$643.4M→$570.0M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-02-06
PRIOR — 2025-02-07
ADDED
The number of outstanding shares of common stock, as of February 2, 2026, was 64,379,735 shares.
Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care.
Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery.
Aptar is headquartered in Crystal Lake, Illinois and has approximately 14,000 employees in approximately 20 different countries.
Consumers and patients' preferences for convenience and product differentiation through drug delivery and packaging design and function are important to our customers and have driven a continued shift from non-dispensing formats to dispensing systems that offer enhanced shelf appeal, ease of use, convenience, cleanliness and accuracy of dosage.
+7 more — sign up free →
REMOVED
The number of outstanding shares of common stock, as of February 3, 2025, was 66,495,293 shares.
Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care, and home care.
Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world.
Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 different countries.
Consumers and patients' preferences for convenience and product differentiation through drug delivery and packaging design and function are important to our customers and they have converted many of their packages from non-dispensing formats to dispensing systems that offer enhanced shelf appeal, ease of use, convenience, cleanliness and accuracy of dosage.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →